Drugs Targeting Kinase Fusions May Boost Outcomes in Some MSI Colorectal Cancers Drugs Targeting Kinase Fusions May Boost Outcomes in Some MSI Colorectal Cancers

In patients with microsatellite instable colorectal cancer harboring druggable kinase fusions, combination therapy targeting specific fusions along with immune checkpoint blockade may improve long-term outcomes, a genomic analysis suggests.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news